世界のOTC医薬品市場予測2023-2029:消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他

【英語タイトル】OTC Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2498)・商品コード:MMG23FB2498
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のOTC医薬品市場規模と予測を収録しています。・世界のOTC医薬品市場:売上、2018年-2023年、2024年-2029年
・世界のOTC医薬品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のOTC医薬品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「消化器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

OTC医薬品のグローバル主要企業は、Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euraditeなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、OTC医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のOTC医薬品市場:タイプ別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場:タイプ別市場シェア、2022年
・消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他

世界のOTC医薬品市場:用途別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場:用途別市場シェア、2022年
・薬局、病院薬局、ネット通販、その他

世界のOTC医薬品市場:地域・国別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるOTC医薬品のグローバル売上、2018年-2023年
・主要企業におけるOTC医薬品のグローバル売上シェア、2022年
・主要企業におけるOTC医薬品のグローバル販売量、2018年-2023年
・主要企業におけるOTC医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite

*************************************************************

・調査・分析レポートの概要
OTC医薬品市場の定義
市場セグメント
世界のOTC医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のOTC医薬品市場規模
世界のOTC医薬品市場規模:2022年 VS 2029年
世界のOTC医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのOTC医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のOTC医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他
OTC医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:薬局、病院薬局、ネット通販、その他
OTC医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別OTC医薬品市場規模 2022年と2029年
地域別OTC医薬品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 OTC Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global OTC Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Medicine Overall Market Size
2.1 Global OTC Medicine Market Size: 2022 VS 2029
2.2 Global OTC Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top OTC Medicine Players in Global Market
3.2 Top Global OTC Medicine Companies Ranked by Revenue
3.3 Global OTC Medicine Revenue by Companies
3.4 Top 3 and Top 5 OTC Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies OTC Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 OTC Medicine Players in Global Market
3.6.1 List of Global Tier 1 OTC Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 OTC Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global OTC Medicine Market Size Markets, 2022 & 2029
4.1.2 Gastrointestinal Tract
4.1.3 Dermatology
4.1.4 Otolaryngology
4.1.5 Nutrition/Vitamins
4.1.6 Others
4.2 By Type – Global OTC Medicine Revenue & Forecasts
4.2.1 By Type – Global OTC Medicine Revenue, 2018-2023
4.2.2 By Type – Global OTC Medicine Revenue, 2024-2029
4.2.3 By Type – Global OTC Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global OTC Medicine Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital Pharmacy
5.1.4 Online Retailer
5.1.5 Others
5.2 By Application – Global OTC Medicine Revenue & Forecasts
5.2.1 By Application – Global OTC Medicine Revenue, 2018-2023
5.2.2 By Application – Global OTC Medicine Revenue, 2024-2029
5.2.3 By Application – Global OTC Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global OTC Medicine Market Size, 2022 & 2029
6.2 By Region – Global OTC Medicine Revenue & Forecasts
6.2.1 By Region – Global OTC Medicine Revenue, 2018-2023
6.2.2 By Region – Global OTC Medicine Revenue, 2024-2029
6.2.3 By Region – Global OTC Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America OTC Medicine Revenue, 2018-2029
6.3.2 US OTC Medicine Market Size, 2018-2029
6.3.3 Canada OTC Medicine Market Size, 2018-2029
6.3.4 Mexico OTC Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe OTC Medicine Revenue, 2018-2029
6.4.2 Germany OTC Medicine Market Size, 2018-2029
6.4.3 France OTC Medicine Market Size, 2018-2029
6.4.4 U.K. OTC Medicine Market Size, 2018-2029
6.4.5 Italy OTC Medicine Market Size, 2018-2029
6.4.6 Russia OTC Medicine Market Size, 2018-2029
6.4.7 Nordic Countries OTC Medicine Market Size, 2018-2029
6.4.8 Benelux OTC Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia OTC Medicine Revenue, 2018-2029
6.5.2 China OTC Medicine Market Size, 2018-2029
6.5.3 Japan OTC Medicine Market Size, 2018-2029
6.5.4 South Korea OTC Medicine Market Size, 2018-2029
6.5.5 Southeast Asia OTC Medicine Market Size, 2018-2029
6.5.6 India OTC Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America OTC Medicine Revenue, 2018-2029
6.6.2 Brazil OTC Medicine Market Size, 2018-2029
6.6.3 Argentina OTC Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa OTC Medicine Revenue, 2018-2029
6.7.2 Turkey OTC Medicine Market Size, 2018-2029
6.7.3 Israel OTC Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia OTC Medicine Market Size, 2018-2029
6.7.5 UAE OTC Medicine Market Size, 2018-2029
7 OTC Medicine Companies Profiles
7.1 Procter & Gamble
7.1.1 Procter & Gamble Company Summary
7.1.2 Procter & Gamble Business Overview
7.1.3 Procter & Gamble OTC Medicine Major Product Offerings
7.1.4 Procter & Gamble OTC Medicine Revenue in Global Market (2018-2023)
7.1.5 Procter & Gamble Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson OTC Medicine Major Product Offerings
7.2.4 Johnson & Johnson OTC Medicine Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc OTC Medicine Major Product Offerings
7.3.4 GlaxoSmithKline Plc OTC Medicine Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Plc Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories OTC Medicine Major Product Offerings
7.4.4 Abbott Laboratories OTC Medicine Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Amway Corporation
7.5.1 Amway Corporation Company Summary
7.5.2 Amway Corporation Business Overview
7.5.3 Amway Corporation OTC Medicine Major Product Offerings
7.5.4 Amway Corporation OTC Medicine Revenue in Global Market (2018-2023)
7.5.5 Amway Corporation Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer OTC Medicine Major Product Offerings
7.6.4 Bayer OTC Medicine Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Aktienge
7.7.1 Aktienge Company Summary
7.7.2 Aktienge Business Overview
7.7.3 Aktienge OTC Medicine Major Product Offerings
7.7.4 Aktienge OTC Medicine Revenue in Global Market (2018-2023)
7.7.5 Aktienge Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi OTC Medicine Major Product Offerings
7.8.4 Sanofi OTC Medicine Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer OTC Medicine Major Product Offerings
7.9.4 Pfizer OTC Medicine Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Reckitt Benckiser Group
7.10.1 Reckitt Benckiser Group Company Summary
7.10.2 Reckitt Benckiser Group Business Overview
7.10.3 Reckitt Benckiser Group OTC Medicine Major Product Offerings
7.10.4 Reckitt Benckiser Group OTC Medicine Revenue in Global Market (2018-2023)
7.10.5 Reckitt Benckiser Group Key News & Latest Developments
7.11 Church & Dwight
7.11.1 Church & Dwight Company Summary
7.11.2 Church & Dwight Business Overview
7.11.3 Church & Dwight OTC Medicine Major Product Offerings
7.11.4 Church & Dwight OTC Medicine Revenue in Global Market (2018-2023)
7.11.5 Church & Dwight Key News & Latest Developments
7.12 Bayer HealthCare
7.12.1 Bayer HealthCare Company Summary
7.12.2 Bayer HealthCare Business Overview
7.12.3 Bayer HealthCare OTC Medicine Major Product Offerings
7.12.4 Bayer HealthCare OTC Medicine Revenue in Global Market (2018-2023)
7.12.5 Bayer HealthCare Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca OTC Medicine Major Product Offerings
7.13.4 AstraZeneca OTC Medicine Revenue in Global Market (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
7.14 BioGaia
7.14.1 BioGaia Company Summary
7.14.2 BioGaia Business Overview
7.14.3 BioGaia OTC Medicine Major Product Offerings
7.14.4 BioGaia OTC Medicine Revenue in Global Market (2018-2023)
7.14.5 BioGaia Key News & Latest Developments
7.15 Bristol Myers Squibb
7.15.1 Bristol Myers Squibb Company Summary
7.15.2 Bristol Myers Squibb Business Overview
7.15.3 Bristol Myers Squibb OTC Medicine Major Product Offerings
7.15.4 Bristol Myers Squibb OTC Medicine Revenue in Global Market (2018-2023)
7.15.5 Bristol Myers Squibb Key News & Latest Developments
7.16 Chr. Hansen
7.16.1 Chr. Hansen Company Summary
7.16.2 Chr. Hansen Business Overview
7.16.3 Chr. Hansen OTC Medicine Major Product Offerings
7.16.4 Chr. Hansen OTC Medicine Revenue in Global Market (2018-2023)
7.16.5 Chr. Hansen Key News & Latest Developments
7.17 Cipla
7.17.1 Cipla Company Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla OTC Medicine Major Product Offerings
7.17.4 Cipla OTC Medicine Revenue in Global Market (2018-2023)
7.17.5 Cipla Key News & Latest Developments
7.18 CoLucid
7.18.1 CoLucid Company Summary
7.18.2 CoLucid Business Overview
7.18.3 CoLucid OTC Medicine Major Product Offerings
7.18.4 CoLucid OTC Medicine Revenue in Global Market (2018-2023)
7.18.5 CoLucid Key News & Latest Developments
7.19 Daiichi Sankyo
7.19.1 Daiichi Sankyo Company Summary
7.19.2 Daiichi Sankyo Business Overview
7.19.3 Daiichi Sankyo OTC Medicine Major Product Offerings
7.19.4 Daiichi Sankyo OTC Medicine Revenue in Global Market (2018-2023)
7.19.5 Daiichi Sankyo Key News & Latest Developments
7.20 Friggs
7.20.1 Friggs Company Summary
7.20.2 Friggs Business Overview
7.20.3 Friggs OTC Medicine Major Product Offerings
7.20.4 Friggs OTC Medicine Revenue in Global Market (2018-2023)
7.20.5 Friggs Key News & Latest Developments
7.21 DSM
7.21.1 DSM Company Summary
7.21.2 DSM Business Overview
7.21.3 DSM OTC Medicine Major Product Offerings
7.21.4 DSM OTC Medicine Revenue in Global Market (2018-2023)
7.21.5 DSM Key News & Latest Developments
7.22 Eisai
7.22.1 Eisai Company Summary
7.22.2 Eisai Business Overview
7.22.3 Eisai OTC Medicine Major Product Offerings
7.22.4 Eisai OTC Medicine Revenue in Global Market (2018-2023)
7.22.5 Eisai Key News & Latest Developments
7.23 Eli Lilly
7.23.1 Eli Lilly Company Summary
7.23.2 Eli Lilly Business Overview
7.23.3 Eli Lilly OTC Medicine Major Product Offerings
7.23.4 Eli Lilly OTC Medicine Revenue in Global Market (2018-2023)
7.23.5 Eli Lilly Key News & Latest Developments
7.24 Herbalife
7.24.1 Herbalife Company Summary
7.24.2 Herbalife Business Overview
7.24.3 Herbalife OTC Medicine Major Product Offerings
7.24.4 Herbalife OTC Medicine Revenue in Global Market (2018-2023)
7.24.5 Herbalife Key News & Latest Developments
7.25 Euradite
7.25.1 Euradite Company Summary
7.25.2 Euradite Business Overview
7.25.3 Euradite OTC Medicine Major Product Offerings
7.25.4 Euradite OTC Medicine Revenue in Global Market (2018-2023)
7.25.5 Euradite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. OTC Medicine Market Opportunities & Trends in Global Market
Table 2. OTC Medicine Market Drivers in Global Market
Table 3. OTC Medicine Market Restraints in Global Market
Table 4. Key Players of OTC Medicine in Global Market
Table 5. Top OTC Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global OTC Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global OTC Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies OTC Medicine Product Type
Table 9. List of Global Tier 1 OTC Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 OTC Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global OTC Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - OTC Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - OTC Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global OTC Medicine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - OTC Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - OTC Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global OTC Medicine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global OTC Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global OTC Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America OTC Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America OTC Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe OTC Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe OTC Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia OTC Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia OTC Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America OTC Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America OTC Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa OTC Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa OTC Medicine Revenue, (US$, Mn), 2024-2029
Table 30. Procter & Gamble Company Summary
Table 31. Procter & Gamble OTC Medicine Product Offerings
Table 32. Procter & Gamble OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 33. Procter & Gamble Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson OTC Medicine Product Offerings
Table 36. Johnson & Johnson OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. GlaxoSmithKline Plc Company Summary
Table 39. GlaxoSmithKline Plc OTC Medicine Product Offerings
Table 40. GlaxoSmithKline Plc OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Plc Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories OTC Medicine Product Offerings
Table 44. Abbott Laboratories OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Amway Corporation Company Summary
Table 47. Amway Corporation OTC Medicine Product Offerings
Table 48. Amway Corporation OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 49. Amway Corporation Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer OTC Medicine Product Offerings
Table 52. Bayer OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Aktienge Company Summary
Table 55. Aktienge OTC Medicine Product Offerings
Table 56. Aktienge OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 57. Aktienge Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi OTC Medicine Product Offerings
Table 60. Sanofi OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer OTC Medicine Product Offerings
Table 64. Pfizer OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Reckitt Benckiser Group Company Summary
Table 67. Reckitt Benckiser Group OTC Medicine Product Offerings
Table 68. Reckitt Benckiser Group OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 69. Reckitt Benckiser Group Key News & Latest Developments
Table 70. Church & Dwight Company Summary
Table 71. Church & Dwight OTC Medicine Product Offerings
Table 72. Church & Dwight OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 73. Church & Dwight Key News & Latest Developments
Table 74. Bayer HealthCare Company Summary
Table 75. Bayer HealthCare OTC Medicine Product Offerings
Table 76. Bayer HealthCare OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 77. Bayer HealthCare Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca OTC Medicine Product Offerings
Table 80. AstraZeneca OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. BioGaia Company Summary
Table 83. BioGaia OTC Medicine Product Offerings
Table 84. BioGaia OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 85. BioGaia Key News & Latest Developments
Table 86. Bristol Myers Squibb Company Summary
Table 87. Bristol Myers Squibb OTC Medicine Product Offerings
Table 88. Bristol Myers Squibb OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 89. Bristol Myers Squibb Key News & Latest Developments
Table 90. Chr. Hansen Company Summary
Table 91. Chr. Hansen OTC Medicine Product Offerings
Table 92. Chr. Hansen OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 93. Chr. Hansen Key News & Latest Developments
Table 94. Cipla Company Summary
Table 95. Cipla OTC Medicine Product Offerings
Table 96. Cipla OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 97. Cipla Key News & Latest Developments
Table 98. CoLucid Company Summary
Table 99. CoLucid OTC Medicine Product Offerings
Table 100. CoLucid OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 101. CoLucid Key News & Latest Developments
Table 102. Daiichi Sankyo Company Summary
Table 103. Daiichi Sankyo OTC Medicine Product Offerings
Table 104. Daiichi Sankyo OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 105. Daiichi Sankyo Key News & Latest Developments
Table 106. Friggs Company Summary
Table 107. Friggs OTC Medicine Product Offerings
Table 108. Friggs OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 109. Friggs Key News & Latest Developments
Table 110. DSM Company Summary
Table 111. DSM OTC Medicine Product Offerings
Table 112. DSM OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 113. DSM Key News & Latest Developments
Table 114. Eisai Company Summary
Table 115. Eisai OTC Medicine Product Offerings
Table 116. Eisai OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 117. Eisai Key News & Latest Developments
Table 118. Eli Lilly Company Summary
Table 119. Eli Lilly OTC Medicine Product Offerings
Table 120. Eli Lilly OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 121. Eli Lilly Key News & Latest Developments
Table 122. Herbalife Company Summary
Table 123. Herbalife OTC Medicine Product Offerings
Table 124. Herbalife OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 125. Herbalife Key News & Latest Developments
Table 126. Euradite Company Summary
Table 127. Euradite OTC Medicine Product Offerings
Table 128. Euradite OTC Medicine Revenue (US$, Mn) & (2018-2023)
Table 129. Euradite Key News & Latest Developments
List of Figures
Figure 1. OTC Medicine Segment by Type in 2022
Figure 2. OTC Medicine Segment by Application in 2022
Figure 3. Global OTC Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global OTC Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global OTC Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by OTC Medicine Revenue in 2022
Figure 8. By Type - Global OTC Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global OTC Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global OTC Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global OTC Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global OTC Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global OTC Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global OTC Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America OTC Medicine Revenue Market Share, 2018-2029
Figure 16. US OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe OTC Medicine Revenue Market Share, 2018-2029
Figure 20. Germany OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia OTC Medicine Revenue Market Share, 2018-2029
Figure 28. China OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America OTC Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa OTC Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE OTC Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. Procter & Gamble OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Plc OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amway Corporation OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aktienge OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Reckitt Benckiser Group OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Church & Dwight OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bayer HealthCare OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. AstraZeneca OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BioGaia OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Bristol Myers Squibb OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Chr. Hansen OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Cipla OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. CoLucid OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Daiichi Sankyo OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Friggs OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. DSM OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Eisai OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Eli Lilly OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Herbalife OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Euradite OTC Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界のOTC医薬品市場予測2023-2029:消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他] (コード:MMG23FB2498)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のOTC医薬品市場予測2023-2029:消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆